By Mrinalika Roy Oct 28 (Reuters) - Women in the US struggling to find hormone replacement treatments to manage menopause ...

Shortages of estrogen patches have spread to injectable and vaginal hormone treatments as demand for menopause therapy rises, ...

Estrogen patches are the most commonly reported shortage in the U.S., but the FDA says it’s working to boost supply.

Demand for menopause drugs is now outpacing supply across multiple estrogen products in the US. After months of tight ...

When 56-year-old Lila Davachi began the menopause transition several years ago, she was caught off guard by the severe brain fog. Davachi, a neuroscientist and professor, knows the brain well. But she ...

FDA approved the first generic Climara Pro, a weekly estrogen-progestin patch, as women report trouble filling patches. What ...

The FDA is facing mounting pressure to declare an estrogen patch shortage as some medical providers say production isn't keeping up with demand.

U.S. Senator Kirsten Gillibrand (D-NY) pressed the Food and Drug Administration (FDA) on its plan to mitigate the estradiol transdermal patch shortage, which is making it harder for women to manage ...

Sen. Kirsten Gillibrand is calling for the FDA to answer the question of why women can't fill estrogen patch prescriptions a year into supply problems.

Tammy Duckworth, Kirsten Gillibrand and Adam Schiff urge the FDA to address the estradiol patch shortage disrupting menopause ...

The U.S. Food and Drug Administration (FDA) approved the first generic version of Climara Pro on Monday. It’s a skin patch ...

AAM highlights essential role generics manufacturers play in supplying estrogen patches; notes the complexity of its production and reasons for not declaring a nationwide shortage ...